Makucell Inc

Novel skin stem cell aesthetic business, with products designed for the cosmetic and OTC topical (non-FDA regulated) markets.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Altadena, CA, USA
  • Currency USD
  • Founded September 2010
  • Employees 2
  • Website makucell.com

Company Summary

Makucell is a regenerative medicine life science technology company focused on utilizing patent-pending core science to manufacture, market, and distribute cosmetic and OTC topical skin, hair and nail care products. Company is utilizing direct to physician, direct to consumer, and sub-licensing of licensed technology along with broad international distribution for revenue generation. The technology represents a game changer for skin/hair care.

Team

  • Kevin J Scanlon
    Chairman/CEO

  • Lawrence A Rheins
    COO - Consultant, Director

    An experienced Scientific Executive with an extensive and diverse career within the cosmetic, personal care, dermatology, biotechnology and medical aesthetics industry. A proven leader with the ability to achieve scientific and technical solutions through the effective utilization of strong team management skills and the execution of assignments in line with corporate objectives. Executive management DermTech, Histogen, Aria.

  • Mark Dahl
    Chief Medical Officer consultant

    Former Chairman, Depts of Dermatology at the Mayo Clinic & Univ of Minn. Former President of the Am Academy of Dermatology; former editor, J Am Acad Dermatology.

  • Kenneth Aldrige
    Advisor

  • Malcolm Currie
    Director

    Former Chairman USC Board of Trustees

  • Lawrence Rheins

Advisors

  • Lee Weinberg, Weinberg Gonser LLP, Los Angeles, CA
    Lawyer
    Unconfirmed

Previous Investors

  • Company Founders
    Unconfirmed
    36 Preferred Shareholders for Series A round
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free